Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's products include control-IQ technology, infusion set, insulin pump products, X2 insulin pump products, among others. In addition, it also offers connected health offerings. Tandem also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Canada, Australia, New Zealand, Saudi Arabia and South Africa. Tandem is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Tandem Diabetes Care Inc Company Overview
- Tandem Diabetes Care Inc Company Snapshot
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc - Pipeline Analysis Overview
- Tandem Diabetes Care Inc - Key Facts
- Tandem Diabetes Care Inc - Major Products and Services
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Pipeline Products Overview
- Control-IQ
- Product Status
- CSII Catheter
- CSII Catheter Product Overview
- CSII Catheter Clinical Trial
- Next Generation Closed Loop
- Next Generation Closed Loop Product Overview
- Next Generation Gswim
- Next Generation Gswim Product Overview
- Sigi Patch Pump
- Sigi Patch Pump Product Overview
- Sigi Patch Pump Clinical Trial
- SteadiSet Infusion Set
- SteadiSet Infusion Set Product Overview
- SteadiSet Infusion Set Clinical Trial
- t:connect Mobile - Biometric Authentication
- t:connect Mobile - Biometric Authentication Product Overview
- t:connect Mobile - Decision Support
- t:connect Mobile - Decision Support Product Overview
- t:connect Mobile - Health App Integration
- t:connect Mobile - Health App Integration Product Overview
- t:slim X3 Insulin Pump
- t:slim X3 Insulin Pump Product Overview
- Tandem Mobi: Tubeless
- Tandem Mobi: Tubeless Product Overview
- Tandem Patch
- Tandem Patch Product Overview
- Tandem Diabetes Care Inc - Key Competitors
- Tandem Diabetes Care Inc - Key Employees
- Tandem Diabetes Care Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tandem Diabetes Care Inc, Recent Developments
- Aug 08, 2024: Tandem Diabetes Care Receives Additional FDA 510(k) Clearance for Tandem Mobi Insulin Pump With Interoperable Technology
- Jul 29, 2024: Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Jun 22, 2024: Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
- Jun 18, 2024: Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
- May 29, 2024: Tandem Mobi Insulin Pump Now Compatible With Dexcom G7 Cgm
- Apr 02, 2024: Tandem Diabetes Care Obtains Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology
- Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
- Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
- Feb 14, 2024: Tandem introduces automated insulin delivery system
- Jan 15, 2024: A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Indication
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc, Key Facts
- Tandem Diabetes Care Inc, Major Products and Services
- Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Ongoing Clinical Trials Summary
- Product Status
- Control-IQ - Product Description
- CSII Catheter - Product Status
- CSII Catheter - Product Description
- CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
- Next Generation Closed Loop - Product Status
- Next Generation Closed Loop - Product Description
- Next Generation Gswim - Product Status
- Next Generation Gswim - Product Description
- Sigi Patch Pump - Product Status
- Sigi Patch Pump - Product Description
- Sigi Patch Pump - Sigi Insulin Management System - First-in-Human Study
- SteadiSet Infusion Set - Product Status
- SteadiSet Infusion Set - Product Description
- SteadiSet Infusion Set - Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People with Type 1 Diabetes
- t:connect Mobile - Biometric Authentication - Product Status
- t:connect Mobile - Biometric Authentication - Product Description
- t:connect Mobile - Decision Support - Product Status
- t:connect Mobile - Decision Support - Product Description
- t:connect Mobile - Health App Integration - Product Status
- t:connect Mobile - Health App Integration - Product Description
- t:slim X3 Insulin Pump - Product Status
- t:slim X3 Insulin Pump - Product Description
- Tandem Mobi: Tubeless - Product Status
- Tandem Mobi: Tubeless - Product Description
- Tandem Patch - Product Status
- Tandem Patch - Product Description
- Tandem Diabetes Care Inc, Key Employees
- Tandem Diabetes Care Inc, Other Locations
- Tandem Diabetes Care Inc, Subsidiaries
- Glossary
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Insulet Corp
- DexCom Inc
- Solara Medical Supplies, Inc.
- Medtronic MiniMed Inc
- Eli Lilly and Co
